Is Stamakort FDA approved?
No. This profile records Stamakort as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE STOMACH PROTECTOR
A-10 Gastric Mucosa Bioregulator Peptide
Stamakort is a gastric-mucosa-derived peptide bioregulator that helps restore stomach lining health. It promotes mucus and bicarbonate secretion, enhances blood flow to the stomach lining, and reduces inflammation. It's used for gastritis, ulcers, and general digestive vulnerability. It helps your stomach rebuild its protective barrier.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Stamakort as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 30 mg orally each morning.
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Increases protective mucus layer (MUC5AC)
Enhances acid-neutralizing secretions
Suppresses NF-κB and inflammatory cytokines
Promotes blood flow to stomach lining
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.